High materiality9/10
H.C. Wainwright Reiterates Buy Rating on Neurogene (NGNE)
Why it may matterVerify against the original reporting
Bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
H.C. Wainwright reiterates Buy rating on NGNE; target price $70; current price $28.60.
- Wainwright reiterates Buy on NGNE; target $70; current $28.60.
Key facts
- 01
Target: $70
- 02
Posted price: $28.6
- 03
Analyst firm: H.C. Wainwright
- 04
Analyst: Mitchel Kapoor
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.